I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

Core Points - I-Mab, a U.S.-based global biotech company, focuses on developing precision immuno-oncology agents for cancer treatment [2] - The management team of I-Mab will participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference, scheduled for February 11-12, 2025 [1] - The conference will include a company presentation and one-on-one meetings, with I-Mab's presentation set for February 11, 2025, from 4:00 to 4:30 PM ET [1] Company Overview - I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey [2] - The company is dedicated to advancing innovative therapies in the field of immuno-oncology [2] Contact Information - Investor and media inquiries can be directed to PJ Kelleher at LifeSci Advisors, with contact details provided [3]